Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
MedTrainer Appoints Erika Gotlieb as Chief Client Officer
MedTrainer, a leading healthcare workforce compliance platform, has announced the appointment of Erika Gotlieb as the company’s first Chief Client Officer. With over 30 years of experience in healthcare technology, Gotlieb brings extensive expertise in building strong client relationships that drive measurable value. In her new role, she will oversee MedTrainer’s client-focused initiatives, ensuring healthcare organizations of all sizes receive proactive guidance and support throughout their compliance and credentialing processes.
Abbott’s Volt PFA System Gets FDA Approval for Atrial Fibrillation
Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company’s Volt PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin commercial PFA cases in the United States and will continue its expansion of sites in the European Union following Volt CE Mark approval earlier this year.
MorseLife Donates $1 Million for Hurricane Melissa Healthcare Relief
MorseLife, a nationally recognized leader in senior care, has pledged $1 million to support relief efforts for underserved communities in Jamaica affected by Hurricane Melissa in October 2025. The donation is directed through Breaking Healthcare Barriers, a South Florida nonprofit focused on expanding access to healthcare for Jamaica’s most vulnerable populations. Funds are being used to provide essential supplies including food, water, clothing, and medical equipment such as wheelchairs and hospital beds to communities in urgent need.
BioFlorida Names Dr. Anthony Japour Chair of Southeast Chapter
BioFlorida, Florida’s leading life sciences association, announced the appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of its Southeast Chapter, effective December 15, 2025. In this role, Dr. Japour will guide efforts to connect and strengthen the life sciences ecosystem across Southeast Florida, helping companies, researchers, investors, and regional partners collaborate and showcase the area’s scientific and innovation strengths.
GC Biopharma Gets IND Approval for COVID-19 mRNA Trial
GC Biopharma, a leading global biopharmaceutical company, announced that South Korea’s Ministry of Food and Drug Safety has approved its Investigational New Drug application for a Phase 1 clinical trial of GC4006A, its mRNA vaccine candidate for COVID-19. The approval comes shortly after the IND submission in September, allowing the company to accelerate its development plans in line with the Korean government’s initiative to localize mRNA vaccine production. GC Biopharma aims to file for Phase 2 IND approval in the second half of 2026.
To share your insights, please write to us at sudipto@intentamplify.com
